Disease stratification in GCA and PMR: state of the art and future perspectives

A Tomelleri, KSM van der Geest, MA Khurshid… - Nature Reviews …, 2023 - nature.com
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related conditions
characterized by systemic inflammation, a predominant IL-6 signature, an excellent …

Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?

G Carvajal Alegria, M Nicolas, Y van Sleen - Frontiers in Immunology, 2023 - frontiersin.org
Research into giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) has become
more important in the last few decades. Physicians are facing several challenges in …

[HTML][HTML] Clinical significance of platelet-lymphocyte ratio in systemic lupus erythematosus patients: Relation to disease activity and damage

NY El-Said, S El Adle, HM Fathi - The Egyptian Rheumatologist, 2022 - Elsevier
Aim of the work To assess platelet–lymphocyte ratio (PLR) in systemic lupus erythematosus
(SLE) patients and study its clinical significance, its relation to disease activity and damage …

Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review

TE Bolhuis, P Bosch, L Falzon, CE Owen… - …, 2024 - academic.oup.com
OBJECTIVE To perform a systematic literature review on definitions and instruments used to
measure remission, relapse, and disease activity in polymyalgia rheumatica (PMR), to …

Measurement properties of the polymyalgia rheumatica activity score: a systematic literature review

TE Bolhuis, LEA Nizet, C Owen… - The Journal of …, 2022 - jrheum.org
Objective. To perform a COnsensus-based Standards for the selection of health
Measurement INstruments (COSMIN)-based systematic literature review of measurement …

Giant Cell Arteritis (GCA): An international, multicentre, longitudinal evaluation of clinical, laboratory and ultrasound parameters in the diagnosis, prognosis and …

AU Rajah Sebastian - 2023 - repository.essex.ac.uk
Background: Giant cell arteritis (GCA) is a vasculitis, varies in extent, severity and outcomes,
hence requires disease stratification for targeted management. Ultrasound (US) non …

[PDF][PDF] The Egyptian Rheumatologist

NY El-Said, S El Adle, HM Fathi - 2021 - researchgate.net
abstract Aim of the work: To assess platelet–lymphocyte ratio (PLR) in systemic lupus
erythematosus (SLE) patients and study its clinical significance, its relation to disease …

What is behind the elevated neutrophil to lymphocyte ratio in glucocorticoid-resistant polymyalgia rheumatica?

H Ito - search.ebscohost.com
What is behind the elevated neutrophil to lymphocyte ratio in glucocorticoid-resistant
polymyalgia rheumatica? Keywords: neutrophil to lymphocyte ratio; platelet to lymphocyte …

Mechanizm, działanie i skuteczność glikokortykosteroidów w polimialgii reumatycznej i olbrzymiokomórkowym zapaleniu tętnic—czy te leki są zawsze skuteczne?

B Grygiel-Górniak, A Szczepańska, M Lubarska… - Varia …, 2021 - journals.viamedica.pl
W terapii polimialgii reumatycznej (PMR, polymialgia rheumatica) i olbrzymiokomórkowego
zapalenia tętnic (GCA, giant cells arthritis) lekami pierwszego wyboru są …

[引用][C] What is behind the elevated neutrophil to lymphocyte ratio in glucocorticoid‐resistant polymyalgia rheumatica?

H Ito - International Journal of Rheumatic Diseases, 2021 - Wiley Online Library
Dear Editor, Owen and colleagues have pointed out that elevated neutrophil to lymphocyte
ratio (NLR) and platelet to lymphocyte ratio (PLR) could predict glucocorticoid resistance …